Literature DB >> 21309585

Polymer-supported organotin reagent for prosthetic group labeling of biological macromolecules with radioiodine.

Andrew N Gifford1, Sonja Kuschel, Colleen Shea, Joanna S Fowler.   

Abstract

In this study, we investigated the use of poly-mer-bound precursor for generating a radiolabeled prosthetic group to be used for conjugate labeling of biological macromolecules. For the approach, a trialkyltin chloride in which the tin was bound to a hydrophilic PEG-based resin support via one of the alkyl groups was synthesized. This resin was then used to prepare a resin-bound trialkyltin benzoic acid, which in some cases was further derivatized on-resin by converting it to a succinimidyl ester. Exposure of the resin-bound compounds to electrophilic radioiodine (¹²⁵I) in either an aqueous or methanol solvent liberated either free radiolabeled [¹²⁵I]iodobenzoic acid or its succinimidyl ester without co-release of the resin-bound precursors. Radiochemical yield was between 35% and 75%, depending on the solvent system and precursor. As example applications for the released compounds, the amine-reactive N-succinimidyl-[¹²⁵I]iodobenzoate prosthetic group was used for conjugate radiolabeling of a peptide, tomato plant systemin, and two proteins, albumin and IgG antibody. These results demonstrate that resin-bound organotin precursors in which the compound to be labeled is tethered to the support via the tin group to be substituted can be used to produce radioiodine-labeled aromatic prosthetic groups in good specific activity without the need for HPLC purification. This solid-phase approach is potentially adaptable to kit-formulation for performing conjugate radiolabeling of biological macromolecules.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309585     DOI: 10.1021/bc1004203

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  2 in total

1.  Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin.

Authors:  Julie E Pickett; Kunihiko Nagakura; Anna R Pasternak; Steven G Grinnell; Susruta Majumdar; Jason S Lewis; Gavril W Pasternak
Journal:  Bioorg Med Chem Lett       Date:  2013-06-06       Impact factor: 2.823

2.  Bifunctional aryliodonium salts for highly efficient radioiodination and astatination of antibodies.

Authors:  F Guérard; L Navarro; Y-S Lee; A Roumesy; C Alliot; M Chérel; M W Brechbiel; J-F Gestin
Journal:  Bioorg Med Chem       Date:  2017-09-19       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.